Literature DB >> 11837539

The cellular pathology of Parkinson's disease.

H Takahashi1, K Wakabayashi.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder of unknown cause that occurs in adults. The presence of Lewy bodies (LB) in association with nerve cell loss in the substantia nigra and various other regions of the nervous system is a diagnostic hallmark of the disease. In 1997, a mutation was identified in the alpha-synuclein gene in families with autosomal dominant PD. Subsequent immunohistochemical studies have revealed that all of the LB in familial and sporadic PD contain the gene product alpha-synuclein: abnormal filaments that constitute LB were clearly recognized by antibodies against alpha-synuclein. Moreover, it was shown that the glial cells, both astrocytes and oligodendrocytes, are also affected by alpha-synuclein pathology. Recently, a novel protein, synphilin-1, has been identified that interacts with alpha-synuclein. Interestingly, synphilin-1 immunohistochemistry has demonstrated that this protein is present in the central core of classical (brainstem) LB, which are composed mainly of densely packed vesicular structures. The role of both alpha-synuclein and synphilin-1 in normal conditions has yet to be clarified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11837539     DOI: 10.1046/j.1440-1789.2001.00403.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  24 in total

1.  Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.

Authors:  Nozomi Hishikawa; Jun-Ichi Niwa; Manabu Doyu; Takashi Ito; Shinsuke Ishigaki; Yoshio Hashizume; Gen Sobue
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

2.  NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.

Authors:  Kunikazu Tanji; Tomoaki Tanaka; Fumiaki Mori; Katsumi Kito; Hitoshi Takahashi; Koichi Wakabayashi; Tetsu Kamitani
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 3.  Parkinson's disease: what the model systems have taught us so far.

Authors:  Swagata Ghatak; Dorit Trudler; Nima Dolatabadi; Rajesh Ambasudhan
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 4.  LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Authors:  Pei Xu; Dabing Li; Xiaotong Tang; Xiaohang Bao; Jing Huang; Yongping Tang; Yang Yang; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

5.  Amyloid aggregates of the deubiquitinase OTUB1 are neurotoxic, suggesting that they contribute to the development of Parkinson's disease.

Authors:  Raniki Kumari; Roshan Kumar; Sanjay Kumar; Abhishek Kumar Singh; Pranita Hanpude; Deepak Jangir; Tushar Kanti Maiti
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

Review 6.  Inflammation as a causative factor in the aetiology of Parkinson's disease.

Authors:  P S Whitton
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

7.  Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Authors:  Maria Jose Catalan; Jose Antonio Molina-Arjona; Pablo Mir; Esther Cubo; Jose Matias Arbelo; Pablo Martinez-Martin
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849

8.  Abnormal localization of leucine-rich repeat kinase 2 to the endosomal-lysosomal compartment in lewy body disease.

Authors:  Shinji Higashi; Darren J Moore; Ryoko Yamamoto; Michiko Minegishi; Kiyoshi Sato; Takashi Togo; Omi Katsuse; Hirotake Uchikado; Yoshiko Furukawa; Hiroaki Hino; Kenji Kosaka; Piers C Emson; Keiji Wada; Valina L Dawson; Ted M Dawson; Heii Arai; Eizo Iseki
Journal:  J Neuropathol Exp Neurol       Date:  2009-09       Impact factor: 3.685

9.  Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years.

Authors:  Ivar Mendez; Angel Viñuela; Arnar Astradsson; Karim Mukhida; Penelope Hallett; Harold Robertson; Travis Tierney; Renn Holness; Alain Dagher; John Q Trojanowski; Ole Isacson
Journal:  Nat Med       Date:  2008-04-06       Impact factor: 53.440

Review 10.  Management of motor and non-motor symptoms in Parkinson's disease.

Authors:  Fabienne Sprenger; Werner Poewe
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.